Browsing by Author Ekiz, Hüseyin Atakan
Showing results 1 to 17 of 17
| Issue Date | Title | Author(s) |
|---|---|---|
| May-2011 | Bioactive sphingolipids in response to chemotherapy: A scope on Leukemias | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| Nov-2021 | Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition | Stephens, W. Zac; Kubinak, Jason L.; Ghazaryan, Arevik; Bauer, Kaylyn M.; Buhrke, Kate; Round, June L.; Ekiz, Hüseyin Atakan |
| Mar-2011 | Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells | Can, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2009 | Imatinib induces autophagy through increasing the expression levels of Beclin-1 and ATG-5 genes in both parental sensitive and imatinib-resistant K562 cells | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan ; Genç, S. G. |
| 2011 | The importance of protein profiling in the diagnosis and treatment of hematologic malignancies | Şanlı Mohamed, Gülşah ; Turan, Taylan; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2023 | Interferon Gamma-Inducible NAMPT in Melanoma Cells Serves as a Mechanism of Resistance to Enhance Tumor Growth | Barba, Cindy; Ekiz, H. Atakan ; Tang, William Weihao; Ghazaryan, Arevik; Hansen, Mason; Lee, Soh-Hyun; Voth, Warren Peter |
| Sep-2022 | miR-aculous new avenues for cancer immunotherapy | Tang, William W.; Bauer, Kaylyn M.; Barba, Cindy; Ekiz, Hüseyin Atakan ; O’Connell, Ryan M. |
| Feb-2010 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts | Ekiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf |
| 2009 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells, as effectively as in parental sensitive counterparts | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan |
| Aug-2022 | PlaqView 2.0: A comprehensive web portal for cardiovascular single-cell genomics | Ma, Wei Feng; Turner, Adam W.; Gancayco, Christina; Wong, Doris; Song, Yipei; Mosquera, Jose Verdezoto; Auguste, Gaëlle; Hodonsky, Chani J.; Prabhakar, Ajay; Ekiz, Hüseyin Atakan ; van der Laan, Sander W.; Miller, Clint L. |
| Sep-2011 | Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells | Avcı, Çığır Biray; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray; Dodurga, Yavuz; Ekiz, Hüseyin Atakan ; Kartal, Melis; Şahin, Fahri; Baran, Yusuf ; Gündüz, Cumhur |
| Mar-2012 | Role of autophagy in the progression and suppression of leukemias | Ekiz, Hüseyin Atakan ; Can, Geylani; Baran, Yusuf |
| 2010 | The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells | Baran, Yusuf ; Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur |
| 2023 | A single-amino acid substitution in the adaptor LAT accelerates TCR proofreading kinetics and alters T-cell selection, maintenance and function | Lo, Wan-Lin; Kuhlmann, Miriam; Rizzuto, Gabrielle; Ekiz, H. Atakan ; Kolawole, Elizabeth M.; Revelo, Monica P.; Andargachew, Rakieb |
| Oct-2010 | Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells | Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur; Dalmızrak, Ayşegül; Yandım, Melis Kartal; Gündüz, Ufuk; Baran, Yusuf |
| Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2010 | Therapeutic potential of targeting sphingolipid signaling pathways in various types of cancers | Baran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde |